Dr. Christine Allen, Co-Founder and CEO of Intrepid Labs, and Dr. Andrew Lewis, Chief Scientific Officer of Quotient Sciences, explain how AI can be used in drug development to shorten development ...
Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design that better anticipates manufacturability ...
The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Formulation Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results